Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
Katelyn M. Atkins(Brigham and Women's Hospital), Raymond H. Mak(Brigham and Women's Hospital), Paul L. Nguyen(Brigham and Women's Hospital), Nayan Lamba(Harvard University), Udo Hoffmann(Massachusetts General Hospital), Danielle S. Bitterman(Brigham and Women's Hospital), Aileen B. Chen(Dana-Farber Cancer Institute), Tafadzwa L. Chaunzwa(Dana-Farber Cancer Institute), Bhupendra Rawal(Harvard University), Anthony V. D’Amico(University of Connecticut), David Kozono(Dana-Farber Cancer Institute), Elizabeth H. Baldini(Dana-Farber Cancer Institute), Hugo J.W.L. Aerts(Maastro Clinic), Christopher L. Williams(Dana-Farber Cancer Institute), Anju Nohria(Brigham and Women's Hospital)
Cited by 270
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
|Circulation|2020|535
Arterial Inflammation in Patients With HIV
|JAMA|2012|460